Pharmaceutical Contract Packaging Market Growth Analysis and Forecast 2026

Pharmaceutical Contract Packaging Market

The global pharmaceutical contract packaging market is witnessing steady growth as pharmaceutical and biotechnology companies increasingly outsource packaging operations to specialized service providers. The global pharmaceutical contract packaging market size was valued at USD 35.78 billion in 2025 and is projected to grow from USD 37.87 billion in 2026 to USD 59.63 billion by 2034, registering a CAGR of 5.84% during the forecast period from 2026 to 2034. North America dominated the pharmaceutical contract packaging market with a 36.5% market share in 2025.

Pharmaceutical contract packaging allows drug manufacturers to access specialized packaging technologies, regulatory expertise, serialization capabilities, and flexible production capacity without making large investments in in-house facilities. Rising pharmaceutical production, growing demand for biologics and specialty medicines, and stricter packaging and traceability requirements are encouraging companies to work with contract packaging organizations.

For detailed market insights, growth forecasts, and competitive analysis, visit: https://straitsresearch.com/report/pharmaceutical-contract-packaging-market

Market Drivers

One of the major factors driving the pharmaceutical contract packaging market is the increasing outsourcing of non-core pharmaceutical activities. Drug manufacturers are focusing their internal resources on research, drug development, clinical trials, and commercialization while outsourcing packaging operations to experienced service providers. This approach can reduce capital requirements while providing access to specialized technologies and trained personnel.

The growing complexity of pharmaceutical products is another important driver. Biologics, injectable drugs, personalized medicines, specialty therapies, and temperature-sensitive products often require carefully designed packaging solutions. Contract packaging providers can offer specialized capabilities for primary, secondary, and tertiary packaging while helping manufacturers maintain product quality throughout distribution.

Strict regulatory requirements are also strengthening demand for professional packaging services. Pharmaceutical products require accurate labeling, tamper-evident packaging, serialization, track-and-trace systems, and detailed quality control. Contract packaging companies with established compliance systems can help manufacturers manage these requirements more efficiently.

Growth in pharmaceutical production worldwide is further creating opportunities. Aging populations, increasing healthcare spending, expanding access to medicines, and continued development of new therapies are increasing the number of pharmaceutical products requiring safe and compliant packaging.

Market Challenges

Maintaining regulatory compliance across different countries remains one of the key challenges for pharmaceutical contract packaging providers. Packaging and labeling requirements can vary significantly between markets. Service providers must continuously update processes, equipment, documentation, and employee training to comply with changing regulations.

Quality and product safety are equally important concerns. Packaging errors involving labels, dosage information, batch numbers, expiry dates, or serialization codes can lead to recalls and financial losses. Companies therefore need strong quality management systems and reliable inspection technologies.

The initial investment required for advanced packaging machinery, automation, serialization systems, cleanroom environments, and digital inspection technologies can also be substantial. Smaller contract packaging organizations may find it difficult to compete with larger providers that have broader technological capabilities.

Supply chain disruptions represent another challenge. Shortages of packaging materials such as glass, plastic, aluminum, paperboard, and specialized components can affect production schedules and increase operating costs.

Market Segmentation

The pharmaceutical contract packaging market can be segmented based on packaging type, material, product type, and end user. Increasing product complexity and regulatory requirements are creating demand for specialized services across these categories.

By Packaging Type

The market includes primary packaging, secondary packaging, and tertiary packaging.

Primary packaging involves materials that come into direct contact with pharmaceutical products, including bottles, blister packs, vials, ampoules, syringes, and sachets. This segment plays an essential role in protecting drugs against contamination, moisture, light, and physical damage.

Secondary packaging includes cartons, boxes, labels, inserts, and other external components. Demand is supported by regulatory labeling requirements, serialization, branding, and patient information needs.

Tertiary packaging is primarily used for transportation and bulk distribution. It includes shipping containers, pallets, and protective packaging designed to reduce damage during storage and logistics.

By Material

Major packaging materials include plastic, glass, paper and paperboard, aluminum, and other specialized materials.

Plastic remains widely used because of its flexibility, lightweight properties, durability, and suitability for bottles, containers, closures, and flexible packaging. Glass continues to play an important role in pharmaceutical applications, particularly for injectable drugs, biologics, and products requiring strong chemical resistance.

Paper and paperboard are commonly used for cartons and secondary packaging. Growing sustainability concerns are encouraging pharmaceutical companies and packaging providers to explore recyclable and lower-impact materials.

By Product Type

The market serves packaging requirements for oral drugs, injectable drugs, biologics, specialty medicines, and other pharmaceutical products.

Oral pharmaceutical products create substantial packaging demand because tablets and capsules are widely distributed through bottles and blister packs. These solutions provide convenient dosing while protecting medicines from environmental exposure.

Injectable drugs and biologics require more specialized packaging because product stability, sterility, and temperature control are critical. Growing development of biologics and specialty therapies is expected to increase demand for high-quality contract packaging capabilities.

By End User

Major end users include pharmaceutical companies, biotechnology companies, generic drug manufacturers, and other healthcare organizations.

Large pharmaceutical companies use contract packaging providers to increase flexibility and manage product launches across multiple geographic markets. Outsourcing can also help manufacturers handle temporary increases in production without investing in additional internal packaging capacity.

Small and mid-sized biotechnology companies can particularly benefit from outsourcing because building dedicated packaging infrastructure requires considerable investment and regulatory expertise.

Regional Insights

North America dominated the pharmaceutical contract packaging market with a 36.5% share in 2025. The region benefits from a large pharmaceutical industry, advanced healthcare infrastructure, strong presence of contract service providers, and high adoption of automated packaging technologies. The United States represents a major contributor due to its extensive pharmaceutical and biotechnology sectors.

Europe represents another significant market. Germany, the United Kingdom, France, Italy, and other European countries have established pharmaceutical manufacturing industries. Strict regulatory standards, serialization requirements, and increasing production of specialty medicines support demand for professional contract packaging services.

Asia-Pacific is expected to provide attractive growth opportunities during the forecast period. China, India, Japan, and South Korea have expanding pharmaceutical manufacturing industries and growing contract manufacturing capabilities. Lower production costs, increasing healthcare demand, and investments in pharmaceutical infrastructure are encouraging further development.

Latin America is gradually expanding as pharmaceutical manufacturing and healthcare access improve. Brazil and Mexico are important regional markets, supported by growing medicine consumption and investment in pharmaceutical production.

The Middle East & Africa market is developing with improvements in healthcare infrastructure, pharmaceutical imports, local manufacturing, and distribution networks. Increasing demand for safe and compliant pharmaceutical packaging is expected to create opportunities for specialized providers.

Key Players Analysis

The pharmaceutical contract packaging market is competitive, with companies focusing on advanced packaging technologies, regulatory compliance, serialization, automation, flexible production, and customized services. Strategic partnerships and expansion of packaging capacity are also helping providers serve pharmaceutical and biotechnology companies across multiple markets.

Key companies operating in the industry include:

Amcor plc
West Pharmaceutical Services Inc.
Catalent Pharma Solutions
PCI Pharma Services
CCL Industries Inc.
Nipro Corporation
SCHOTT AG
Gerresheimer AG
AptarGroup Inc.
Berry Global Inc.
Sharp Packaging Services
Almac Group
WestRock Company
Wasdell Group
Tjoapack B.V.

Competition is expected to increasingly focus on automation, sustainability, digital traceability, specialized biologic packaging, and the ability to meet complex regulatory requirements.

Conclusion

The pharmaceutical contract packaging market is expected to maintain steady growth through 2034 as pharmaceutical manufacturers increasingly outsource specialized packaging operations. Rising drug production, stricter regulatory requirements, increasing adoption of serialization, and growing demand for biologics and specialty medicines are strengthening the need for reliable contract packaging services.

With the market projected to grow from USD 37.87 billion in 2026 to USD 59.63 billion by 2034 at a CAGR of 5.84%, contract packaging providers have opportunities to expand through automation, sustainable materials, digital technologies, and specialized packaging solutions. North America’s strong pharmaceutical ecosystem is expected to maintain its important position, while developing pharmaceutical industries across Asia-Pacific are likely to create additional growth opportunities.

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.